![](/img/cover-not-exists.png)
Results of a phase I/II open-label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients
Martinowitz, U., Lissitchkov, T., Lubetsky, A., Jotov, G., Barazani-Brutman, T., Voigt, C., Jacobs, I., Wuerfel, T., Santagostino, E.Volume:
21
Language:
english
Journal:
Haemophilia
DOI:
10.1111/hae.12721
Date:
November, 2015
File:
PDF, 292 KB
english, 2015